PGS6 COST EFFECTIVENESS OF CONTINUOUS AND ON-DEMAND THERAPY WITH ESOMEPRAZOLE 20MG IN PATIENTS WITH SYMPTOMATIC GASTROESOPHGEAL REFLUX DISEASE (GERD)- THE ONE STUDY
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61751-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)61751-2/fulltext
Title :
PGS6 COST EFFECTIVENESS OF CONTINUOUS AND ON-DEMAND THERAPY WITH ESOMEPRAZOLE 20MG IN PATIENTS WITH SYMPTOMATIC GASTROESOPHGEAL REFLUX DISEASE (GERD)- THE ONE STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61751-2&doi=10.1016/S1098-3015(10)61751-2
First page :
Section Title :
Open access? :
No
Section Order :
197